Considering treatment for Crohn’s Disease with HUMIRA

If you are still experiencing symptoms, your current treatment may not have your moderate to severe Crohn’s Disease under control and HUMIRA may help.

Humira and Crohn’s Disease

HUMIRA has been proven to induce and maintain remission (little or no symptoms) in many people with moderate to severe Crohn’s Disease.

If you’re like others who’ve not responded well enough or have lost response to your current Crohn’s Disease treatments, such as aminosalicylates, corticosteroids, immunomodulators, or another biologic, ask your gastroenterologist about HUMIRA.

Disease control may be possible with HUMIRA.§

HUMIRA is only available with a prescription, so if you are still experiencing symptoms of Crohn’s Disease despite your current treatment, ask your gastroenterologist to see if HUMIRA is right for you.

The government medicine funding agency, PHARMAC, fully subsidises HUMIRA if your Crohn’s Disease has not fully responded to other medicines prescribed by a specialist, and you meet other criteria required by PHARMAC. Your specialist will discuss whether HUMIRA is right for you, and whether you may qualify for PHARMAC funded treatment. Usual doctor’s consultation fees, and pharmacy prescription charges remain payable by you.

HUMIRA has been used for the treatment of Crohn’s Disease by Gastroenterologists in New Zealand since 2009.

HUMIRA has been studied in clinical trials up to 4 years. Based on clinical trial results with 4 years follow-up, many of those adults who may respond or achieve remission initially with HUMIRA for Crohn’s Disease will continue to benefit over time.§

In 2019, a New Zealand study call Vitality aimed to look at the effects of HUMIRA on health and disability wellbeing outcomes in patients with Crohn’s disease, rheumatoid arthritis or psoriasis treated in routine clinical practice in New Zealand. Over 160 patients with these conditions were enrolled. The primary measure evaluated was the WHODAS 2.0 (World Health Organization Disability Assessment Schedule), a disability assessment measure developed by the World Health Organisation. Further validated scores looking at factors such as work productivity, mental distress and others were also studied. The study researchers concluded that 6 months treatment with HUMIRA significantly^ improved health and disability in New Zealand patients with Crohn’s disease, rheumatoid arthritis and psoriasis.

^ Change in total WHODAS 2.0 score at 6 months vs baseline. p<0.001

Find out more from our list of useful resources about Crohn’s Disease that has been collated from New Zealand and overseas.

HUMIRA Safety Information

Safety information on this website includes some of the more important information to know about HUMIRA.

Read More 

How does HUMIRA work?

HUMIRA is a fully human monoclonal antibody. HUMIRA recognises and binds to a specific protein (tumour necrosis factor or TNF-alpha), which is present at increased levels in inflammatory diseases such as Crohn’s Disease .

Read More 

Starting and taking HUMIRA

What you need to know about taking HUMIRA, including free support to help you get the best out of your HUMIRA treatment.

Read More 


When should I expect to see and feel a difference?

HUMIRA can act quickly; most people with Crohn’s Disease can expect to see improvement in their symptoms within 3 months and in some cases as early as four weeks.§ It is possible that no effect is seen after HUMIRA treatment. Discuss your expectations with your doctor.

You’ll need to be patient and stay on track with your dosing schedule as advised by your gastroenterologist. Some patients may not respond within these timeframes.



Will HUMIRA cure my disease?

Unfortunately, currently there are no treatments available that can cure Crohn’s Disease.


Talk with your doctor

We’ve put together a checklist that you can take along to your gastroenterologist visit to discuss symptoms and treatment options.

Download your ‘Getting ready for your gastroenterologist visit’ guide

Download your guide